Pitt Shield

Role of P<sub>2</sub> × <sub>7</sub> receptor during focused ultrasound induced blood brain barrier modulation.

Authors: Park J, Na YC, Lee J, Seo Y, Kim H, Han S, Song BW, Chang WS

Although low-intensity focused ultrasound (LiFUS) with microbubbles is used to temporally open the blood-brain barrier (BBB), the underlying mechanism is not fully understood. This study aimed to analyze BBB-related alterations in the brain microenvironment after LiFUS, with a focus on the involvement of the purinergic P<sub>2</sub> × <sub>7</sub> receptor. Sprague-Dawley rats were sonicated with LiFUS at 0.3 MPa energy. The impact of LiFUS on the P<sub>2</sub> × <sub>7</sub> receptor and inflammatory-related proteins, including NLRP3 and interleukin-1β, was analyzed through western blotting. The BBB-associated tight junction proteins, zonula occludens-1 (ZO-1) and occludin, were also analyzed. BBB permeability was assessed by quantifying the amount of Evans blue dye penetration using spectrophotometry. Furthermore, the safety of the sonication procedure was verified via terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay and hematoxylin and eosin staining. Substantial increases in the P<sub>2</sub> × <sub>7</sub> receptor and its downstream signaling were confirmed after sonicating the BBB with LiFUS for 1 h (p < 0.05). Conversely, for tight junction proteins, the lowest expression was observed at 1 h (p < 0.001). Both responses were normalized back to the original state over time. No evidence of brain damage was observed during the procedure. Furthermore, the P<sub>2</sub> × <sub>7</sub> receptor antagonist-injected group showed reduced Evans blue dye penetration compared to that 1 h after FUS, indicating a mitigated impact of LiFUS on the BBB. Herein, we elucidate the underlying mechanism by which LiFUS affects the BBB, with a focus on the involvement of the P<sub>2</sub> × <sub>7</sub> receptor. Our findings demonstrate that the extent of BBB opening varies upon the regulation of the P<sub>2</sub> × <sub>7</sub> receptor. This study provides valuable insights into the mechanisms underlying BBB modulation through LiFUS, thereby laying the foundation for expanding its applications.

Introduction

Purpose Drug delivery with BBB opening
Study Objective To determine whether and how low-intensity focused ultrasound (LiFUS) modulates the blood–brain barrier by involving the purinergic P2X7 receptor, through analysis of molecular, inflammatory, and permeability changes in rat brain tissue.
Animal model / Human subject Rat (Sprague-Dawley), 7 weeks old, male
Disease model healthy
MRI or image guidance method MRI
Targeted brain region(s) Hippocampus
Target coordinates AP -3.5 mm (posterior to bregma), ML +2.0 mm (lateral);
Cargo name and characteristics P2X7 receptor antagonist A430879 ; Evans blue dye ; Gadobutrol
Route of administration intravenous

Outcomes and Safety

Summary of Outcomes LiFUS (0.5 MHz transducer with microbubbles at ~0.3 MPa) transiently opened the BBB—peaking at 1 h with increased P2X7 receptor, NLRP3, and IL-1β and decreased tight junction proteins (ZO‑1, occludin) that normalized by 24 h—without detectable tissue damage, and P2X7 receptor antagonism reduced Evans blue leakage.
Duration of biological effect 24 h
Safety-related matter LiFUS at 0.3 MPa induced a transient inflammatory response (upregulation of P2X7, NLRP3, IL-1β, NF-κB peaking at 1–4 h and normalizing by 24 h) but TUNEL and H&E assays showed no evidence of cell damage or hemorrhage; the authors conclude the procedure is safe under the defined parameters. They nevertheless advise vigilance for potential edema or hemorrhage post-sonication and caution when translating findings to diseased states.

Brain Region

Ultrasound Parameters

Ultrasound instrument H-107MR, Sonic Concept Inc
FUS Frequency 515 kHz
FUS Intensity not provided
FUS Pressure 0.3 MPa
FUS Mode pulsed
Pulse duration 10 ms
Duration of a single FUS session 2 min
Focal Characteristics 51.74 mm
Treatment frequency single session

We are open to feedback. If you see a mistake or have a suggestion, please contact us.

← Back to Search